These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9049195)

  • 1. Autoimmune hepatitis in childhood: a 20-year experience.
    Gregorio GV; Portmann B; Reid F; Donaldson PT; Doherty DG; McCartney M; Mowat AP; Vergani D; Mieli-Vergani G
    Hepatology; 1997 Mar; 25(3):541-7. PubMed ID: 9049195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study.
    Gregorio GV; Portmann B; Karani J; Harrison P; Donaldson PT; Vergani D; Mieli-Vergani G
    Hepatology; 2001 Mar; 33(3):544-53. PubMed ID: 11230733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease.
    Han S; Tredger M; Gregorio GV; Mieli-Vergani G; Vergani D
    Hepatology; 1995 Jan; 21(1):58-62. PubMed ID: 7806169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of autoantibodies in the study of autoimmune liver diseases and prevalence of autoimmune extrahepatic manifestations].
    Montes Santiago J; Gambón Deza F; García García MJ; González Vázquez L; Hermo Brión JA; Pérez Alvarez R
    An Med Interna; 2000 Jul; 17(7):343-6. PubMed ID: 10981329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable outcomes of autoimmune hepatitis in a community clinic setting.
    Seo S; Toutounjian R; Conrad A; Blatt L; Tong MJ
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1410-4. PubMed ID: 18373564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis.
    Kanzler S; Weidemann C; Gerken G; Löhr HF; Galle PR; Meyer zum Büschenfelde KH; Lohse AW
    J Hepatol; 1999 Oct; 31(4):635-40. PubMed ID: 10551386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis.
    Zauli D; Ghetti S; Grassi A; Descovich C; Cassani F; Ballardini G; Muratori L; Bianchi FB
    Hepatology; 1997 May; 25(5):1105-7. PubMed ID: 9141425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological liver diseases in children.
    Mieli-Vergani G; Vergani D
    Semin Liver Dis; 1998; 18(3):271-9. PubMed ID: 9773427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.
    Ichai P; Duclos-Vallée JC; Guettier C; Hamida SB; Antonini T; Delvart V; Saliba F; Azoulay D; Castaing D; Samuel D
    Liver Transpl; 2007 Jul; 13(7):996-1003. PubMed ID: 17370335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune hepatitis in children: what is different from adult AIH?
    Mieli-Vergani G; Vergani D
    Semin Liver Dis; 2009 Aug; 29(3):297-306. PubMed ID: 19676002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis].
    Bakker-Jonges LE; ter Borg PC; van Buuren HR; Hooijkaas H
    Ned Tijdschr Geneeskd; 2006 Mar; 150(9):490-4. PubMed ID: 16553048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis.
    Czaja AJ; Cassani F; Cataleta M; Valentini P; Bianchi FB
    Hepatology; 1996 Nov; 24(5):1068-73. PubMed ID: 8903377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for autoimmune hepatitis.
    Reich DJ; Fiel I; Guarrera JV; Emre S; Guy SR; Schwartz ME; Miller CM; Sheiner PA
    Hepatology; 2000 Oct; 32(4 Pt 1):693-700. PubMed ID: 11003612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive histological damage in liver allografts following pediatric liver transplantation.
    Evans HM; Kelly DA; McKiernan PJ; Hübscher S
    Hepatology; 2006 May; 43(5):1109-17. PubMed ID: 16628633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Three patients with autoimmune hepatitis: the importance of early diagnosis and remission].
    Kroep JR; Bolk JH; Weverling-Rijnsburger AW; van Hoek B
    Ned Tijdschr Geneeskd; 2005 Oct; 149(44):2437-41. PubMed ID: 16285356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LKM-positive autoimmune hepatitis in the western United States: a case series.
    Duchini A; McHutchison JG; Pockros PJ
    Am J Gastroenterol; 2000 Nov; 95(11):3238-41. PubMed ID: 11095348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.